Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Journal of Microbiology and Related Research

Volume  1, Issue 1,  2015, Pages 29-35
 

Review Article

Ebola Hemorrhagic Fever

Dalip K Kakru, Mohd Suhail, Nargis Bali, Junaid Ahmad, Humaira Bashir

*Professor & Head, ** Senior Resident, ***Resident, Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar.190011 Kashmir. ****Senior Resident, Department of Microbiology, GMC, Srinagar, Kashmir

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI:

Abstract
Ebola virus disease (EVD) also known as Ebola haemorrhagic fever is a severe contagious disease affecting humans and non-human primates. It is usually transmitted to humans through direct contact with blood, tissue, body fluids and secretions from an infected animal or human. The causative agent is classified in the genus Ebolavirus of the Filoviridae family. Filoviruses are filamentous enveloped viruses containing a non-segmented, negative-strand genomic RNA of approximately 19 kilobases. Patients are diagnosed by testing of body fluids and serum with an ELISA test/ PCR; however the results are not always accurate. There is currently no treatment for Ebola hemorrhagic fever. Vaccines are in clinical trials and hold the future in preventing this disease. Ebola is on the United States’ list of possible bioterrorism agents because no humans have been found to have immunity to it. 

 


Corresponding Author : Dalip K Kakru